XX Die Zeitschrift für Frauen in der Medizin 2012; 1(5): 264-268
DOI: 10.1055/s-0032-1331340
Themen & Trends
© Georg Thieme Verlag Stuttgart · New York

Reif für die Praxis? – Die nicht-invasive Pränataldiagnostik aus dem Blut Schwangerer

Wolfgang Holzgreve
Further Information

Publication History

Publication Date:
09 January 2013 (online)

Nach 20 Jahren Forschung ist es gelungen, einen Test zu entwickeln, mit dem ohne Risiken für das Ungeborene bestimmt werden kann, ob genetische oder chromosomale Störungen vorliegen.

 
  • Literatur

  • 1 Ferguson-Smith MA, Yates JWR. Maternal age-specific rates for chromosomal aberrations and factors influencing them: Report of a collaborative European study on 52 965 amnisocenteses. Prenat Diagn (Special Issue) 1984; 4-4
  • 2 Holzgreve W. Ethik in der ppränatalen Medizin- geht sie voran oder läuft sie hinterher?. Editorial. Ther. Umschau 2006; 63: 681-682
  • 3 Hahn S, Holzgreve W. Fetal cells and cell free DNA in maternal blood: new insights into preeclampsia. Hum Reprod Update 2002; 6: 501-508
  • 4 Holzgreve W, Hahn S, Zhong XY et al. Genetic communication between fetus and mother: short- and long-term consequences. Am J Obstet Gynecol 2007; 196: 372-381
  • 5 Bischoff FZ, Hahn S, Johanson KL et al. Intact fetal cells in maternal plasma. Lancet 2003; 361: 139-140
  • 6 Lo YMD, Corbetta N, Chamberlain PF et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997; 350: 485-487
  • 7 Lun FMF, Tsui NB, Chan KC et al. Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on maternal DNA in maternal plasma. PNAS 2008; 105: 19920-19925
  • 8 Zhong XY, Hahn S, Holzgreve W. Prenatal identification of fetal genetic traits. Lancet 2001; 357: 310-311
  • 9 Li Y, Hahn S, Holzgreve W. Recent developments in the detection of fetal single gene differences in maternal plasma and the role of size fractionation. Ann NY Acad Sci 2006; 1092: 285-292
  • 10 Huang DJ, Nelson MR, Holzgreve W. Maldi-TOF-Mass spectrometry for trisomy detection. Methods Mol Biol 2008; 444: 123-132
  • 11 Mergenthaler-Gatfield S, Holzgreve W, Hahn S. Spectral karyotyping (SKY) applications in prenatal diagnositics. Methods Mol Biol 2008; 444: 3-26
  • 12 Zweifelhofer T, Tynan J, Cagasan L et al. Multiplexed massively parallel sequencing for the prenatal detection of fetal aneuploidy from maternal plasma. SCMM optimization study . Poster presented at the 2010 Annual Meeting of the American Society of Human Genetics (ASHG), Washington DC.
  • 13 Chiu RWK, Akolehar R, Zheng YWL et al. Noninvasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011; 342: 7401-7401
  • 14 Ehrich M, Deciu C, Zweifelhofer T et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011; 204: 1-11
  • 15 Bianchi D, Platt L, Goldberg J, Abuhamad JA et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Am J Obstet Gynecol 2012; 206: 1-15
  • 16 Ashoor A, Syndelaki A, Wagner M, Birdir C, Nicolaides K. Chromosome-selective sequencing of maternal plasma cell-free DNA for first trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 206: 1-5
  • 17 Palomaki GE, Kloza EM, Lambert-Messerlian GM et al. DNA sequencing of maternal plasma to detect Down's syndrome: an international clinical validation. Genet Med 2011; 13: 913-920
  • 18 Palomaki G, Deciu C, Kloza EM et al. DNA Sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: An International Collaborative Study. Genet Med 2012; 14: 296-305
  • 19 Tschudin S, Holzgreve W, Conde N et al. Pregnant women's assessment and level of knowledge of prenatal counceling. Ultraschall Med 2009; 30: 157-162